{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:37:55Z","timestamp":1792021075845,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"a Grant-in-Aid for Intractable Renal Diseases Research, Research on Rare and Intractable Diseases, Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18ek0109354h0001"],"award-info":[{"award-number":["18ek0109354h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chugai Pharmaceutical Co."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lupus nephritis (LN) is a life-threatening complication of systemic lupus erythematosus. The 2003 pathological classification of LN was revised in 2016; it quantitatively evaluates the interstitium in addition to the glomeruli. We performed a retrospective multi-centre cohort study and investigated the utility of the 2016 classification\u2014including the activity index (AI), chronicity index (CI), and each pathological component to predict complete remission or renal function decline, defined as 1.5-fold increase in serum creatinine levels\u2014and compare with that of the 2003 classification. Ninety-one consecutive adult patients with first-onset class III\/IV LN who were newly prescribed any immunosuppressants were enrolled and followed up for a median of 51\u00a0months from January 2004. Cox regression analysis demonstrated the subclasses based on the 2003 classification, which mainly evaluate glomerular lesions, were not associated with clinical outcomes. After adjustments for estimated glomerular filtration rate and urinary protein levels, higher CI and higher interstitial fibrosis and lower hyaline deposit scores were associated with renal functional decline. Similarly, higher CI and interstitial inflammation scores were associated with failure to achieve complete remission. Therefore, the 2016 classification can predict the clinical outcomes more precisely than the 2003 classification.<\/jats:p>","DOI":"10.1038\/s41598-020-78972-1","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T11:03:35Z","timestamp":1610708615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The ISN\/RPS 2016 classification predicts renal prognosis in patients with first-onset class III\/IV lupus nephritis"],"prefix":"10.1038","volume":"11","author":[{"given":"Asaka","family":"Hachiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munetoshi","family":"Karasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritoshi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Ishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotake","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"78972_CR1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/cjn.05780616","volume":"12","author":"S Almaani","year":"2017","unstructured":"Almaani, S., Meara, A. & Rovin, B. H. Update on lupus nephritis. Clin. J. Am. Soc. Nephrol. CJASN 12, 825\u2013835. https:\/\/doi.org\/10.2215\/cjn.05780616 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"78972_CR2","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/art.38006","volume":"65","author":"CC Mok","year":"2013","unstructured":"Mok, C. C., Kwok, R. C. & Yip, P. S. Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus. Arthritis Rheum. 65, 2154\u20132160. https:\/\/doi.org\/10.1002\/art.38006 (2013).","journal-title":"Arthritis Rheum."},{"key":"78972_CR3","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/rheumatology\/kep012","volume":"48","author":"MI Danila","year":"2009","unstructured":"Danila, M. I. et al. Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Rheumatology (Oxford, England) 48, 542\u2013545. https:\/\/doi.org\/10.1093\/rheumatology\/kep012 (2009).","journal-title":"Rheumatology (Oxford, England)"},{"key":"78972_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/ki.1994.70","volume":"45","author":"HA Austin 3rd","year":"1994","unstructured":"Austin, H. A. 3rd., Boumpas, D. T., Vaughan, E. M. & Balow, J. E. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int. 45, 544\u2013550. https:\/\/doi.org\/10.1038\/ki.1994.70 (1994).","journal-title":"Kidney Int."},{"key":"78972_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/0002-9343(87)90645-0","volume":"83","author":"GB Appel","year":"1987","unstructured":"Appel, G. B., Cohen, D. J., Pirani, C. L., Meltzer, J. I. & Estes, D. Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am. J. Med. 83, 877\u2013885. https:\/\/doi.org\/10.1016\/0002-9343(87)90645-0 (1987).","journal-title":"Am. J. Med."},{"key":"78972_CR6","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1002\/art.20666","volume":"50","author":"FA Houssiau","year":"2004","unstructured":"Houssiau, F. A. et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum. 50, 3934\u20133940. https:\/\/doi.org\/10.1002\/art.20666 (2004).","journal-title":"Arthritis Rheum."},{"key":"78972_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2215\/cjn.03280807","volume":"3","author":"YE Chen","year":"2008","unstructured":"Chen, Y. E., Korbet, S. M., Katz, R. S., Schwartz, M. M. & Lewis, E. J. Value of a complete or partial remission in severe lupus nephritis. Clin. J. Am. Soc. Nephrol. CJASN 3, 46\u201353. https:\/\/doi.org\/10.2215\/cjn.03280807 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"78972_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13075-018-1576-1","volume":"20","author":"H Hanaoka","year":"2018","unstructured":"Hanaoka, H., Iida, H., Kiyokawa, T., Takakuwa, Y. & Kawahata, K. Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV. Arthritis Res. Ther. 20, 86. https:\/\/doi.org\/10.1186\/s13075-018-1576-1 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"78972_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening, J. J. et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 65, 521\u2013530. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00443.x (2004).","journal-title":"Kidney Int."},{"key":"78972_CR10","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1111\/j.1523-1755.2004.66027.x","volume":"66","author":"H Yokoyama","year":"2004","unstructured":"Yokoyama, H. et al. The outcome and a new ISN\/RPS 2003 classification of lupus nephritis in Japanese. Kidney Int. 66, 2382\u20132388. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.66027.x (2004).","journal-title":"Kidney Int."},{"issue":"Suppl","key":"78972_CR11","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.3346\/jkms.2009.24.S1.S7","volume":"24","author":"KE Sada","year":"2009","unstructured":"Sada, K. E. & Makino, H. Usefulness of ISN\/RPS classification of lupus nephritis. J. Korean Med. Sci. 24(Suppl), S7-10. https:\/\/doi.org\/10.3346\/jkms.2009.24.S1.S7 (2009).","journal-title":"J. Korean Med. Sci."},{"key":"78972_CR12","first-page":"239","volume":"37","author":"TK Chow","year":"2015","unstructured":"Chow, T. K., Looi, L. M. & Cheah, P. L. A comparison of 1995 WHO classification with 2003 ISN\/RPS classification of lupus nephritis: a single centre observation. Malays. J. Pathol. 37, 239\u2013246 (2015).","journal-title":"Malays. J. Pathol."},{"key":"78972_CR13","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/rheumatology\/ken019","volume":"47","author":"N Hiramatsu","year":"2008","unstructured":"Hiramatsu, N. et al. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Rheumatology (Oxford, England) 47, 702\u2013707. https:\/\/doi.org\/10.1093\/rheumatology\/ken019 (2008).","journal-title":"Rheumatology (Oxford, England)"},{"key":"78972_CR14","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1097\/00000478-200608000-00015","volume":"30","author":"PN Furness","year":"2006","unstructured":"Furness, P. N. & Taub, N. Interobserver reproducibility and application of the ISN\/RPS classification of lupus nephritis-a UK-wide study. Am. J. Surg. Pathol. 30, 1030\u20131035. https:\/\/doi.org\/10.1097\/00000478-200608000-00015 (2006).","journal-title":"Am. J. Surg. Pathol."},{"key":"78972_CR15","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1681\/asn.2015040384","volume":"26","author":"S Wilhelmus","year":"2015","unstructured":"Wilhelmus, S. et al. The revisited classification of GN in SLE at 10 years: time to re-evaluate histopathologic lesions. J. Am. Soc. Nephrol. JASN 26, 2938\u20132946. https:\/\/doi.org\/10.1681\/asn.2015040384 (2015).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"78972_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/ndt\/gfm555","volume":"23","author":"C Grootscholten","year":"2008","unstructured":"Grootscholten, C. et al. Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis. Nephrol. Dial. Transpl. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Renal Assoc. 23, 223\u2013230. https:\/\/doi.org\/10.1093\/ndt\/gfm555 (2008).","journal-title":"Nephrol. Dial. Transpl. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Renal Assoc."},{"key":"78972_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2215\/cjn.03580414","volume":"10","author":"S Wilhelmus","year":"2015","unstructured":"Wilhelmus, S. et al. Interobserver agreement on histopathological lesions in class III or IV lupus nephritis. Clin. J. Am. Soc. Nephrol. CJASN 10, 47\u201353. https:\/\/doi.org\/10.2215\/cjn.03580414 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"78972_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ki.2012.409","volume":"83","author":"LH Wu","year":"2013","unstructured":"Wu, L. H. et al. Inclusion of renal vascular lesions in the 2003 ISN\/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney Int. 83, 715\u2013723. https:\/\/doi.org\/10.1038\/ki.2012.409 (2013).","journal-title":"Kidney Int."},{"key":"78972_CR19","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1177\/0961203318776109","volume":"27","author":"B Obrisca","year":"2018","unstructured":"Obrisca, B. et al. Histological predictors of renal outcome in lupus nephritis: the importance of tubulointerstitial lesions and scoring of glomerular lesions. Lupus 27, 1455\u20131463. https:\/\/doi.org\/10.1177\/0961203318776109 (2018).","journal-title":"Lupus"},{"key":"78972_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/ckj\/sfx093","volume":"11","author":"PC Wilson","year":"2018","unstructured":"Wilson, P. C., Kashgarian, M. & Moeckel, G. Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritis. Clin. Kidney J. 11, 207\u2013218. https:\/\/doi.org\/10.1093\/ckj\/sfx093 (2018).","journal-title":"Clin. Kidney J."},{"key":"78972_CR21","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ki.2010.13","volume":"77","author":"F Yu","year":"2010","unstructured":"Yu, F. et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 international society of nephrology and renal pathology society system. Kidney Int. 77, 820\u2013829. https:\/\/doi.org\/10.1038\/ki.2010.13 (2010).","journal-title":"Kidney Int."},{"key":"78972_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/acr.20441","volume":"63","author":"C Hsieh","year":"2011","unstructured":"Hsieh, C. et al. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res. 63, 865\u2013874. https:\/\/doi.org\/10.1002\/acr.20441 (2011).","journal-title":"Arthritis Care Res."},{"key":"78972_CR23","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2215\/cjn.10601016","volume":"12","author":"EC Rijnink","year":"2017","unstructured":"Rijnink, E. C. et al. Clinical and histopathologic characteristics associated with renal outcomes in lupus nephritis. Clin. J. Am. Soc. Nephrol. CJASN 12, 734\u2013743. https:\/\/doi.org\/10.2215\/cjn.10601016 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"78972_CR24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema, I. M. et al. Revision of the international society of nephrology\/renal pathology society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int. 93, 789\u2013796. https:\/\/doi.org\/10.1016\/j.kint.2017.11.023 (2018).","journal-title":"Kidney Int."},{"key":"78972_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","volume":"75","author":"HA Austin 3rd","year":"1983","unstructured":"Austin, H. A. 3rd. et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am. J. Med. 75, 382\u2013391. https:\/\/doi.org\/10.1016\/0002-9343(83)90338-8 (1983).","journal-title":"Am. J. Med."},{"key":"78972_CR26","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg, M. C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40, 1725. https:\/\/doi.org\/10.1002\/art.1780400928 (1997).","journal-title":"Arthritis Rheum."},{"key":"78972_CR27","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo, S. et al. Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kid. Dis. Off. J. Natl. Kidney Found. 53, 982\u2013992. https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.034 (2009).","journal-title":"Am. J. Kid. Dis. Off. J. Natl. Kidney Found."},{"issue":"Suppl 11","key":"78972_CR28","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1002\/acr.20572","volume":"63","author":"J Romero-Diaz","year":"2011","unstructured":"Romero-Diaz, J., Isenberg, D. & Ramsey-Goldman, R. Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index (SDI). Arthritis Care Res. 63(Suppl 11), S37-46. https:\/\/doi.org\/10.1002\/acr.20572 (2011).","journal-title":"Arthritis Care Res."},{"key":"78972_CR29","first-page":"1620","volume":"10","author":"HA Austin 3rd","year":"1995","unstructured":"Austin, H. A. 3rd., Boumpas, D. T., Vaughan, E. M. & Balow, J. E. High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol. Dial. Transpl. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Renal Assoc. 10, 1620\u20131628 (1995).","journal-title":"Nephrol. Dial. Transpl. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Renal Assoc."},{"key":"78972_CR30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ki.1984.75","volume":"25","author":"HA Austin 3rd","year":"1984","unstructured":"Austin, H. A. 3rd., Muenz, L. R., Joyce, K. M., Antonovych, T. T. & Balow, J. E. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 25, 689\u2013695. https:\/\/doi.org\/10.1038\/ki.1984.75 (1984).","journal-title":"Kidney Int."},{"key":"78972_CR31","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/ki.2009.243","volume":"76","author":"DC Cattran","year":"2009","unstructured":"Cattran, D. C. et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 76, 534\u2013545. https:\/\/doi.org\/10.1038\/ki.2009.243 (2009).","journal-title":"Kidney Int."},{"key":"78972_CR32","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/ki.2012.280","volume":"82","author":"J Radhakrishnan","year":"2012","unstructured":"Radhakrishnan, J. & Cattran, D. C. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2013application to the individual patient. Kidney Int. 82, 840\u2013856. https:\/\/doi.org\/10.1038\/ki.2012.280 (2012).","journal-title":"Kidney Int."},{"key":"78972_CR33","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1681\/asn.2008101028","volume":"20","author":"GB Appel","year":"2009","unstructured":"Appel, G. B. et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J. Am. Soc. Nephrol. JASN 20, 1103\u20131112. https:\/\/doi.org\/10.1681\/asn.2008101028 (2009).","journal-title":"J. Am. Soc. Nephrol. JASN"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78972-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78972-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78972-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:01:28Z","timestamp":1670032888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78972-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["78972"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78972-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"8 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was supported in part by a Grant-in-Aid for Intractable Renal Diseases Research, Research on Rare and Intractable Diseases, Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan (H29-nanchi-ippan-017.) for S.M; Japan Agency for Medical Research and Development (18ek0109354h0001.) for S.M; a fund from Chugai Pharmaceutical Co. for S.M. However, the funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. All other authors declared no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1525"}}